123 related articles for article (PubMed ID: 24171957)
21. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
[TBL] [Abstract][Full Text] [Related]
22. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia.
Nucifora G; Birn DJ; Erickson P; Gao J; LeBeau MM; Drabkin HA; Rowley JD
Blood; 1993 Feb; 81(4):883-8. PubMed ID: 8427996
[TBL] [Abstract][Full Text] [Related]
23. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype.
Andrieu V; Radford-Weiss I; Troussard X; Chane C; Valensi F; Guesnu M; Haddad E; Viguier F; Dreyfus F; Varet B; Flandrin G; Macintyre E
Br J Haematol; 1996 Mar; 92(4):855-65. PubMed ID: 8616078
[TBL] [Abstract][Full Text] [Related]
24. Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia.
van de Locht LT; Smetsers TF; Wittebol S; Raymakers RA; Mensink EJ
Leukemia; 1994 Oct; 8(10):1780-4. PubMed ID: 7523801
[TBL] [Abstract][Full Text] [Related]
25. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ
J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
[TBL] [Abstract][Full Text] [Related]
26. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
27. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
28. Complex chromosome abnormality mimicking t(8;21)in an acute myeloblastic leukemia.
Busson-Le Coniat M; Daniel M; Berger R
Ann Genet; 2001; 44(1):9-11. PubMed ID: 11334611
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization analysis of masked (8;21)(q22;q22) translocations.
Harrison CJ; Radford-Weiss I; Ross F; Rack K; le Guyader G; Vekemans M; Macintyre E
Cancer Genet Cytogenet; 1999 Jul; 112(1):15-20. PubMed ID: 10432929
[TBL] [Abstract][Full Text] [Related]
30. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21).
Nucifora G; Dickstein JI; Torbenson V; Roulston D; Rowley JD; Vardiman JW
Leukemia; 1994 Sep; 8(9):1533-8. PubMed ID: 7522291
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic profile predictive of KIT activating mutations in AML1-ETO leukemia.
De J; Zanjani R; Hibbard M; Davis BH
Am J Clin Pathol; 2007 Oct; 128(4):550-7. PubMed ID: 17875504
[TBL] [Abstract][Full Text] [Related]
32. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
Wang YY; Zhou GB; Yin T; Chen B; Shi JY; Liang WX; Jin XL; You JH; Yang G; Shen ZX; Chen J; Xiong SM; Chen GQ; Xu F; Liu YW; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1104-9. PubMed ID: 15650049
[TBL] [Abstract][Full Text] [Related]
33. Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.
Zhen T; Wu CF; Liu P; Wu HY; Zhou GB; Lu Y; Liu JX; Liang Y; Li KK; Wang YY; Xie YY; He MM; Cao HM; Zhang WN; Chen LM; Petrie K; Chen SJ; Chen Z
Sci Transl Med; 2012 Mar; 4(127):127ra38. PubMed ID: 22461642
[TBL] [Abstract][Full Text] [Related]
34. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO.
Kuchenbauer F; Schnittger S; Look T; Gilliland G; Tenen D; Haferlach T; Hiddemann W; Buske C; Schoch C
Br J Haematol; 2006 Sep; 134(6):616-9. PubMed ID: 16938118
[TBL] [Abstract][Full Text] [Related]
35. Molecular cytogenetic investigations in a novel complex variant of t(8;21)(q22;q22) with ins(15;21)(q15;q22.2q22.3) in a patient with AML-M2 subtype.
Kokate P; Ahmad F; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jul; 184(1):52-6. PubMed ID: 18558290
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia.
Moon HW; Shin S; Kim HY; Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Chun H; Kim HC; Park CJ; Min YH; Lee DS
Leukemia; 2006 Aug; 20(8):1408-13. PubMed ID: 16791271
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of 8;21 chromosomal translocation without AML1 gene involvement in MDS-AML.
Kawano S; Miyanishi S; Shimizu K; Tanaka K; Okumura A; Ohki M; Kamada N; Ohno Y
Br J Haematol; 1997 Dec; 99(3):632-40. PubMed ID: 9401077
[TBL] [Abstract][Full Text] [Related]
38. Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia.
Chang KS; Fan YH; Stass SA; Estey EH; Wang G; Trujillo JM; Erickson P; Drabkin H
Oncogene; 1993 Apr; 8(4):983-8. PubMed ID: 8455949
[TBL] [Abstract][Full Text] [Related]
39. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
40. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]